<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01351376</url>
  </required_header>
  <id_info>
    <org_study_id>10-00923</org_study_id>
    <nct_id>NCT01351376</nct_id>
  </id_info>
  <brief_title>LLLT Combined With CDT in Breast Cancer-Related Lymphedema</brief_title>
  <official_title>The Effectiveness of Low Level Laser Therapy (LLLT)Combined With Complex Decongestive Therapy (CDT) in the Treatment of Breast Cancer-Related Lymphedema: A Double-Blind, Randomized, Placebo-Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New York University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>New York University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to explore the effects of Low Level Laser Therapy (LLLT) on breast
      cancer-related lymphedema when utilized in conjunction with Complex Decongestive Therapy
      (CDT) when compared to CDT treatment alone. The investigators hypothesize that the addition
      of LLLT to CDT will result in statistically significant improvements and greater long-term
      benefits as measured by changes in arm volume and girth, pain levels, tissue texture,
      symptoms experienced, and quality of life when compared to the benefits of CDT alone for the
      treatment of breast cancer-related lymphedema.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">July 2017</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Arm Volume</measure>
    <time_frame>5-6 measurements over the course of 13-14 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>5-6 measurements over a course of 12-13 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Breast Cancer</condition>
  <condition>Lymphedema</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>CDT + inactive LLL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LLL combined with CDT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>CDT + active LLL</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Low Level Laser Therapy</intervention_name>
    <description>Placebo LLL combined with CDT</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Low Level Laser</other_name>
    <other_name>Complex Decongestive Therapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Low Level Laser</intervention_name>
    <description>Active LLL combined with CDT</description>
    <arm_group_label>LLL combined with CDT</arm_group_label>
    <other_name>Complex Decongestive Therapy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  unilateral breast cancer with ipsilateral lumpectomy or mastectomy and lymph node
             dissection (sentinel biopsy or axillary dissection)

          -  stage II or III unilateral secondary upper extremity lymphedema (as defined by the
             International Society of Lymphology)

          -  girth ≥ 2 cm circumferential difference and/or volume ≥ 200 mL compared to the
             uninvolved upper extremity at any 4 cm segment

          -  able to commit to a long term follow-up schedule

        Exclusion Criteria:

          -  active cancer/metastatic cancer

          -  currently receiving or have plans for adjuvant radiation or chemotherapy

          -  pregnant

          -  presence of other extremity lymphedema (primary or secondary)

          -  pacemaker

          -  artificial joints in the upper quadrants

          -  renal failure

          -  arterial insufficiency

          -  congestive heart failure

          -  chronic inflammatory conditions

          -  history of deep vein thrombosis (DVT) in the lymphedematous upper extremity

          -  previous treatment with Low Level Laser (regardless of indication)

          -  medication(s) known to affect body fluid balance

          -  body mass index (BMI) &gt; 40 (morbid obesity)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Teresa Denham, PT, MA</last_name>
    <role>Principal Investigator</role>
    <affiliation>NYU Rusk Institute of Rehabilitation Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>NYU Clinical Cancer Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NYU Rusk Institute of Rehabilitation Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tisch Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 9, 2011</study_first_submitted>
  <study_first_submitted_qc>May 9, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 10, 2011</study_first_posted>
  <last_update_submitted>September 8, 2017</last_update_submitted>
  <last_update_submitted_qc>September 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lymphedema, Low Level Laser, Breast Cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Lymphedema</mesh_term>
    <mesh_term>Breast Cancer Lymphedema</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>December 5, 2017</submitted>
    <returned>January 2, 2018</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

